Tag: pancreatic_cancer
-
Media Monitor: PolitiFact examines Collins' voting record with Trump, fact-checks election fraud claims and Senate race ads
PolitiFact is reporting on its fact-checks, including Sen. Susan Collins' voting record with Donald Trump, claims of California election fraud, and ads in Iowa, Michigan, and Ohio Senate races.
Politics and GovernmentHealthMediaBusinessGeneral PoliticsFederal GovernmentElectionMedical ScienceSocial Issues Susan CollinsDonald TrumpU.S. SenateFact-checkingElectionsJeffrey EpsteinPancreatic CancerPolitiFact
-
Media Monitor: Primary Election Results, ICE Bill, and "Toy Story 5" Premiere Among Top Stories
USA TODAY reports on primary election outcomes, a $70 billion ICE and Border Patrol bill, a new pancreatic cancer drug, and Taylor Swift's appearance at the 'Toy Story 5' premiere.
Politics and GovernmentEntertainmentHealthSportGeneral PoliticsFilm and TVMedical ScienceEconomyLaw Enforcement Primary ElectionsGraham PlatnerImmigration EnforcementPancreatic CancerTaylor SwiftSerena WilliamsInflationUSA TODAY Daily Briefing
-
Experimental Drug Doubles Survival for Metastatic Pancreatic Cancer
A new experimental drug has demonstrated remarkable success, doubling the median survival rate for patients with metastatic pancreatic cancer. This breakthrough offers a dramatic shift in treatment, bringing renewed hope to those affected.
HealthBusinessScience & TechnologyEntertainmentMedical ScienceEconomyEmployment and LaborEducation Pancreatic CancerMetastatic CancerExperimental DrugCancer TreatmentMedical ResearchSurvival RateOncology
-
Media Monitor: CBS Denies Joe Rogan '60 Minutes' Rumors; Pancreatic Cancer Drug Shows Promise
PolitiFact reports CBS News has debunked social media rumors about Joe Rogan joining "60 Minutes." It also highlights a clinical trial where an experimental pill nearly doubled pancreatic cancer patients' survival.
MediaHealth Joe RoganCBS News60 MinutesPancreatic CancerClinical TrialsDaraxonrasibMedical ResearchPolitiFact's Ellen Hine
-
Yale Highlights Breakthroughs in Environmental History, Medical Research, and Economic Policy
Yale University showcases new research on New Haven's environmental history, critical insights into pancreatic cancer, and links between long COVID and autoimmune responses, alongside discussions on personalized pricing.
HealthBusinessScience & TechnologyEducationMedical ScienceEconomySocial IssuesComputers and Internet Yale UniversityNew HavenEnvironmental HistoryPancreatic CancerLong COVIDAutoimmune ResponsesPersonalized PricingUniversity
-
Yale Scientists Advance Pancreatic Cancer Research and Challenge Evolutionary Theory
Yale researchers are tackling the deadly challenges of pancreatic cancer and offering hope for future treatments. Concurrently, new studies on cavefish are overturning long-held evolutionary beliefs about species in underground ecosystems.
HealthScience & TechnologyMediaPolitics and GovernmentMedical ScienceEducationGeneral PoliticsDigital and Print PublishingFilm and TV Pancreatic CancerCancer ResearchEvolutionary BiologyCavefishYale UniversityLuisa Escobar-HoyosScientific ResearchUniversity
-
Media Monitor: Pancreatic Cancer Drug Shows Promising Clinical Trial Results
The Washington Post is reporting that a new pill, daraxonrasib, has shown promising results in a clinical trial for pancreatic cancer, doubling patient survival compared to standard chemotherapy.
HealthScience & TechnologyMedical Science DaraxonrasibClinical trialPancreatic cancerChemotherapyMedical researchDrug developmentThe Washington Post
-
Media Monitor: Experimental Pill Shows Success Against Pancreatic Cancer
The Washington Post reports on an experimental pill demonstrating unprecedented success in treating pancreatic cancer, challenging previous medical understanding.
HealthScience & TechnologyMediaMedical ScienceDigital and Print Publishing Pancreatic cancerExperimental pillCancer treatmentMedical researchDiseaseMedicineThe Washington Post
-
Media Monitor: NPR reports on art's anti-aging benefits, new pancreatic cancer treatments, and NAD+ supplement efficacy
NPR is reporting on a new study suggesting art engagement can slow biological aging, promising genetic treatments for pancreatic cancer, and the limited evidence for NAD+ longevity supplements.
HealthScience & TechnologyMediaMedical ScienceEducationSocial Issues Art EngagementBiological AgingPancreatic CancerNAD+Genetic TherapiesCancer TreatmentWellnessNPR Health